Research on the causes, course, and detection of cognitive impairment in ethnic minorities has begun to bear fruit, particularly over the last ten years. However, in the United States, studies of cognition in African American and Hispanic elderly have far outpaced those in Asian Americans, the largest minority group in the Pacific Northwest, and rates of participation of minorities in mainstream research on dementia continue to be relatively low. The University of Washington ADRC Satellite seeks to identify and enroll older Asian Americans in a NACC-compliant registry for research, emphasizing early stage cognitive decline, encouraging participation in ongoing research projects, and, in keeping with the Center's strong focus on genetic factors in dementia, identifying and locating familial cases for studies of genetic differences. We have the unique opportunity to resume studies of nearly 2000 older Japanese Americans enrolled in the NIA-funded Kame project over 10 years ago. The first 18 months of the proposed project will be dedicated to developing essential infrastructure for these aims, convening a new Community Advisory Board, creating a computerized family history database from raw research records, and identifying subjects who may be appropriate for dementia-related studies. We will emphasize (1) US-born Japanese with a positive family history of dementia, especially those with 'loaded' families; (2) Individuals with and without dementia who are willing to be contacted as potential subjects in research on cognitive impairment; and (3) Individuals who had begun to show early signs of cognitive decline from normal during their last Kame assessment. During the remainder of the funding period, up to 200 Japanese American subjects will be individually re-evaluated using both the Cognitive Abilities Screening Instrument, for continuity with earlier Kame data and Satellite projects, and the NACC Uniform Data Set.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1-ZIJ-7 (J4))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Washington
United States
Zip Code
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Tulloch, Jessica; Leong, Lesley; Chen, Sunny et al. (2018) APOE DNA methylation is altered in Lewy body dementia. Alzheimers Dement 14:889-894
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Kunji, Khalid; Ullah, Ehsan; Nato Jr, Alejandro Q et al. (2018) GIGI-Quick: a fast approach to impute missing genotypes in genome-wide association family data. Bioinformatics 34:1591-1593
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124
Taylor, Laura M; McMillan, Pamela J; Liachko, Nicole F et al. (2018) Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration. Mol Neurodegener 13:7

Showing the most recent 10 out of 753 publications